Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6983203rdf:typepubmed:Citationlld:pubmed
pubmed-article:6983203lifeskim:mentionsumls-concept:C0006837lld:lifeskim
pubmed-article:6983203lifeskim:mentionsumls-concept:C0006852lld:lifeskim
pubmed-article:6983203lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:6983203lifeskim:mentionsumls-concept:C0027444lld:lifeskim
pubmed-article:6983203lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:6983203lifeskim:mentionsumls-concept:C1442469lld:lifeskim
pubmed-article:6983203lifeskim:mentionsumls-concept:C0699517lld:lifeskim
pubmed-article:6983203pubmed:issue4lld:pubmed
pubmed-article:6983203pubmed:dateCreated1983-1-7lld:pubmed
pubmed-article:6983203pubmed:abstractTextIn 88 patients with vaginal Candida albicans a treatment was performed with natamycin vaginal cream for 6 days in daily doses of 5 ml at concentrations 25 mg natamycin/5 ml (Pim-25), 50 mg natamycin/5 ml (Pim-50), and 100 mg natamycin/5 ml (Pim-100). The cure rates, assessed according to negative cultures of swabs 4-7 days after discontinuation of the treatment, were 89.3%, 85.7%, and 96.9% respectively. Swabs taken about 2 weeks after the next menstrual period showed cure rates of 67.9%, 67.9%, and 78.1% respectively. There was no statistically significant difference in the results between the three groups at the 5% level in Fisher's exact test. The recurrence rate was high in all three groups.lld:pubmed
pubmed-article:6983203pubmed:languageenglld:pubmed
pubmed-article:6983203pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6983203pubmed:citationSubsetIMlld:pubmed
pubmed-article:6983203pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6983203pubmed:statusMEDLINElld:pubmed
pubmed-article:6983203pubmed:issn0001-6349lld:pubmed
pubmed-article:6983203pubmed:authorpubmed-author:BAYSS MSMlld:pubmed
pubmed-article:6983203pubmed:authorpubmed-author:ChristensenE...lld:pubmed
pubmed-article:6983203pubmed:issnTypePrintlld:pubmed
pubmed-article:6983203pubmed:volume61lld:pubmed
pubmed-article:6983203pubmed:ownerNLMlld:pubmed
pubmed-article:6983203pubmed:authorsCompleteYlld:pubmed
pubmed-article:6983203pubmed:pagination325-8lld:pubmed
pubmed-article:6983203pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:meshHeadingpubmed-meshheading:6983203-...lld:pubmed
pubmed-article:6983203pubmed:year1982lld:pubmed
pubmed-article:6983203pubmed:articleTitleVaginal Candida albicans treated with three different concentrations of natamycin (Pimafucin) for 6 days.lld:pubmed
pubmed-article:6983203pubmed:publicationTypeJournal Articlelld:pubmed